Medical Oncologist
CION Cancer Clinics
Tumour budding and newer prognostic markers in colon cancer | CION Cancer Clinics
Tumour budding means loose cancer cells were seen breaking away from the edge of the tumour. A high budding grade suggests a cancer more likely to spread, so it can affect whether surgery or chemotherapy is advised. This page explains how budding is graded, where it changes a decision, and what the newer markers on some reports are trying to measure. At CION Cancer Clinics, our team goes through your reports with you and plans the next test or treatment step.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does tumour budding mean on a colon cancer report?
- How does the pathologist decide low, intermediate or high?
- Where does budding actually affect your treatment?
- What are the other newer markers doctors talk about?
- Three things families assume about budding
- What this page cannot tell you
- Common questions about tumour budding
The short answer
What does tumour budding mean on a colon cancer report?
Tumour budding means the pathologist saw single cancer cells, or tiny clumps of up to four cells, breaking away from the edge of the tumour. These buds sit at the deepest point where the cancer is pushing into healthy tissue. The report grades budding as low, intermediate or high, and a high grade suggests a cancer that is more likely to spread.
Why a few loose cells matter
A tumour with a smooth, pushing edge tends to stay where it is for longer. A tumour shedding loose cells at its edge has started to behave more restlessly. Those loose cells are the ones most able to slip into small vessels and lymph channels. Budding is a picture of that behaviour, frozen on a glass slide.
What it is not
Budding is not a stage and it is not a separate cancer. It does not change the T, N or M letters on your report. It is one of several features under the microscope, alongside grade and invasion of vessels or nerves, that help doctors judge risk within the same stage.
A high budding grade raises the level of caution. It does not decide what will happen to you.Under the microscope
How does the pathologist decide low, intermediate or high?
Finding the invasive front
The pathologist looks at the slides from the deepest part of the tumour, where cancer meets the healthy bowel wall. Budding is judged there, not in the middle of the tumour.
Picking the busiest spot
The whole front is scanned at low power. The single area with the most loose cells, called the hotspot, is chosen for the count.
Counting the buds
Every single cell or small cluster of up to four cells in that one field is counted. Larger clumps are not buds and are recorded separately, if at all.
Giving the grade
An international scoring system turns the count into three grades, written Bd1, Bd2 and Bd3. Bd1 is low, Bd2 is intermediate and Bd3 is high. A special stain is sometimes used to see the cells more clearly, but the grade is normally given on the standard slide.
Not sure whether this applies to you?
Ask an oncologistWhen it changes a decision
Where does budding actually affect your treatment?
Budding matters most where a decision is close. Where the decision is already clear, it adds very little.
After a cancerous polyp is removed
When early cancer is found inside a polyp removed at colonoscopy, the question is whether that was enough. Intermediate or high budding is one of the features that makes the team more likely to advise an operation to check the nearby lymph nodes.
Read alongside
- How deep the cancer reached
- Whether the cut edge was clear
- Grade and invasion of small vessels
Stage 2 and the chemotherapy question
In stage 2, the lymph nodes are clear and chemotherapy after surgery is not automatic. High budding is now listed by several international guidelines among the high-risk features that can tip the discussion towards it.
Stage 3 and stage 4
Once cancer has reached the lymph nodes or spread further, treatment is already decided by those findings. Budding is still recorded, but it rarely changes the plan the tumour board recommends.
If your report does not mention budding at this stage, nothing has been missed that would change your treatment.Beyond budding
What are the other newer markers doctors talk about?
Budding belongs to a wider group of newer markers. They all try to answer the same question: within one stage, whose cancer is more likely to return? Some are reported routinely. Others are mainly used in research or in a few laboratories.
Poorly differentiated clusters and tumour deposits
Poorly differentiated clusters are larger clumps of cancer cells that have lost their gland shape. They carry a similar warning to budding. Tumour deposits are small islands of cancer in the fat near the bowel, away from a lymph node. Deposits are already counted in the standard staging system.
Immune cell scores
Some laboratories measure how many of the body's own immune cells have moved into the tumour. A crowded tumour tends to behave better. These scores are not offered by most laboratories, and no decision should wait for one.
Tumour DNA in the blood
After surgery, a blood test can look for fragments of tumour DNA. Finding them is a strong warning sign. Whether the result should change chemotherapy is still being studied, which is covered on our page about ctDNA testing after surgery. Your MSI status also shapes the outlook, in a different way.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
Three things families assume about budding
"High budding means the cancer will come back."
It means the risk is higher than in a similar cancer without it. Many people with high budding never have a recurrence. It is one weight on the scale, not the result.
"Low budding means chemotherapy can be skipped."
Not on its own. Stage, lymph node count, grade, MSI status and your general health are read together. Low budding helps, but it cannot cancel a finding such as cancer in the lymph nodes.
"My report has no budding grade, so the laboratory missed it."
Not every laboratory reports it on every specimen, and it can be hard to judge on a small biopsy. If it would change your decision, the slides can be reviewed again.
Being straight with you
What this page cannot tell you
It cannot tell you what your own budding grade means for you. That depends on every other line of your report, read together by people who have seen the slides. Budding is also one of the harder features to score consistently, and two pathologists can sometimes grade the same slide differently.
Who this does not apply to
If you have had only a small biopsy and no operation yet, budding usually cannot be judged reliably, and the grade that matters will come from the surgical pathology report. If your tumour is in the rectum, budding is scored the same way but decisions follow a different path on our rectal cancer pages. Once cancer has spread to the liver or lungs, budding rarely guides the plan.
Who can answer it
At CION, the tumour board reviews your pathology report alongside your scans before a plan is confirmed. The pathology itself is done by the partner laboratory that examined your tissue. If a borderline decision rests on budding, ask whether a second look at the slides is worth arranging.
Questions we are asked
Common questions about tumour budding
Is tumour budding the same as the cancer spreading?
No. Budding describes how the edge of the tumour looks under the microscope. Spread is shown by cancer in lymph nodes or other organs. High budding suggests the tumour has a greater tendency to spread, which is why doctors take it seriously, but it is not proof that spread has happened.
What do Bd1, Bd2 and Bd3 mean?
They are the three grades of budding. Bd1 is low, Bd2 is intermediate and Bd3 is high. The grade comes from counting loose cancer cells in the busiest area at the tumour's edge. Higher grades carry more caution, especially in early cancers and stage 2.
Will high budding mean I need chemotherapy?
Not automatically. In stage 2 it is one of several features that can favour chemotherapy, and the decision also weighs your age, health and MSI status. Our page on the stage 2 chemotherapy dilemma explains how that balance is struck.
My polyp was removed and showed budding. Do I need surgery?
Possibly. Intermediate or high budding in a cancerous polyp raises the chance that cancer cells reached nearby lymph nodes. The team weighs it with depth, margin and grade. Some people are advised an operation; others are watched with repeat colonoscopy.
Can budding be measured on a biopsy?
Sometimes, but not reliably. A small biopsy often does not include the deepest edge of the tumour, which is where budding is graded. The grade that guides decisions usually comes from the polyp removed whole or from the operation specimen.
Does budding affect rectal cancer too?
Yes. It is graded the same way in rectal cancer. Rectal cancer is often treated with radiation or chemotherapy before surgery, which can make budding harder to read and changes how decisions are made. Those questions belong to the rectal cancer pages.
Should I ask for my slides to be reviewed again?
It is reasonable when budding sits on the border between grades and the chemotherapy or surgery decision depends on it. Your oncologist can tell you whether a second review would change anything. If it would not, the review only adds time.
Can CION look at my report and tell me what it means?
Yes. Bring the full pathology report, scan reports and any blood test results to a consultation or a second opinion. The tumour board reads budding together with everything else. Call the helpline if you are unsure which documents to bring.
Your Specialists
Meet CION's colon cancer specialists. Bring your colonoscopy, scan or biopsy report.
Our surgical and medical oncologists plan colon cancer care together: which operation, whether chemotherapy is needed, and the follow-up that comes after.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Surgical Pathology Reports
- National Cancer Institute — Colon Cancer Treatment (PDQ), Health Professional Version
- Cancer Research UK — Stages, types and grades of bowel cancer
- National Cancer Institute — Cancer Prognosis
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
High-risk features in stage 2 diseaseWhere budding sits among the features that tip the chemotherapy decisionLymphovascular and perineural invasionThe two report findings most often read beside buddingGrade and differentiation in colon cancerWhat well, moderately and poorly differentiated meanReading your surgical pathology reportEvery line of the operation report, in order
Talk to us
Does a line on your pathology report worry you?
Send us your pathology and scan reports, and an oncologist will explain what budding and the other findings mean for your plan. One helpline serves every CION centre.